(Q43127554)

English

Peroxisome proliferator-activated receptor-gamma(PPARgamma) agonist improves coronary artery endothelial function in diabetic patients with coronary artery disease

scientific article published in January 2010

In more languages

default values for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Peroxisome proliferator-activated receptor-gamma(PPARgamma) agonist improves coronary artery endothelial function in diabetic patients with coronary artery disease (English)

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

0 references

author name string

J Yu

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Z Zhang

2

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Z Li

3

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

X Feng

4

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

L He

5

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

S Liu

6

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

J Mao

7

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

G Wang

8

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

X Wang

9

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

publication date

1 January 2010

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Journal of International Medical Research

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

38

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

1

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

86-94

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

Non-invasive assessment of coronary flow and coronary flow reserve by transthoracic Doppler echocardiography: a magic tool for the real world

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Metabolic and additional vascular effects of thiazolidinediones.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Effect of rosiglitazone treatment on nontraditional markers of cardiovascular disease in patients with type 2 diabetes mellitus

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Pioglitazone, a PPARgamma agonist, restores endothelial function in aorta of streptozotocin-induced diabetic rats.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

PPARγ activation, by reducing oxidative stress, increases NO bioavailability in coronary arterioles of mice with Type 2 diabetes

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Peroxisome proliferator-activated receptor-gamma agonist rosiglitazone reduces clinical inflammatory responses in type 2 diabetes with coronary artery disease after coronary angioplasty

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Peroxisome proliferator-activated receptor gamma agonist improves arterial stiffness in patients with type 2 diabetes mellitus and coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Antidiabetic rosiglitazone reduces soluble intercellular adhesion molecule-1 level in type 2 diabetic patients with coronary artery disease

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

AHA/ACC Guidelines for Secondary Prevention for Patients With Coronary and Other Atherosclerotic Vascular Disease: 2006 Update

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Modulation of PPARgamma activity with pharmaceutical agents: treatment of insulin resistance and atherosclerosis

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Regulation of the Hedgehog and Wingless signalling pathways by the F-box/WD40-repeat protein Slimb

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

The peroxisome proliferator-activated receptor-gamma is a negative regulator of macrophage activation

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Peroxisome proliferator-activated receptor gamma activators inhibit gene expression and migration in human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Expression of the peroxisome proliferator-activated receptor gamma (PPARgamma) in human atherosclerosis and regulation in macrophages by colony stimulating factors and oxidized low density lipoprotein

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Expression and function of PPARgamma in rat and human vascular smooth muscle cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Peroxisome proliferator-activated receptor gamma ligands increase release of nitric oxide from endothelial cells

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Effects of pioglitazone on lipoproteins, inflammatory markers, and adipokines in nondiabetic patients with metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Peroxisome proliferator-activated receptor-gamma activation with pioglitazone improves endothelium-dependent dilation in nondiabetic patients with major cardiovascular risk factors

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

The peroxisome proliferator-activated receptor-gamma agonist pioglitazone increases number and function of endothelial progenitor cells in patients with coronary artery disease and normal glucose tolerance.

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

A potent activator of PPARalpha and gamma reduces the vascular cell recruitment and inhibits the intimal thickning in hypercholesterolemic rabbits

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Effects of rosiglitazone on lipids, adipokines, and inflammatory markers in nondiabetic patients with low high-density lipoprotein cholesterol and metabolic syndrome

1 reference

https://api.crossref.org/works/10.1177%2F147323001003800110

21 January 2018

Identifiers

10.1177/147323001003800110

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

14 November 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q43127554&oldid=1981360148"